Human Factors Engineering (HFE)

The systematic identification and mitigation of hazards arising from the user interface rather than device failure. This process maps all potential interaction points between the user and the device to anticipate errors.

• Task Analysis: Deconstructs user actions into discrete perceptual, cognitive, and physical steps.
• Hazard Identification: Pinpoints where a user might press the wrong button, misinterpret a display, or skip a critical step.
• Risk Control: Implements design barriers like physical guards, confirmation dialogs, or auditory alarms to prevent harm before it occurs.

A formal definition of the intended user populations and the physical environments where the device will be operated. This ensures the design accommodates real-world variability, not just ideal laboratory conditions.

• User Capabilities: Documents the range of vision, hearing, literacy, and dexterity among clinicians, patients, or lay caregivers.
• Environmental Constraints: Accounts for lighting levels, ambient noise, vibration, and the presence of personal protective equipment.
• Use Scenarios: Defines both normal operation and foreseeable misuse, such as a nurse using a device during a code blue emergency.

Iterative, small-scale evaluations conducted early in the design process to identify usability problems and guide design refinement. The focus is on qualitative observation of user errors and difficulties.

• Think-Aloud Protocol: Users verbalize their thought process while interacting with a prototype, revealing their mental model.
• Rapid Prototyping: Tests low-fidelity mockups (paper or wireframes) before committing to expensive engineering builds.
• Root Cause Analysis: Investigates why an error occurred—was the icon ambiguous, the workflow illogical, or the feedback delayed?

A final, rigorous, protocol-driven test conducted on the production-equivalent device to demonstrate safe and effective use. This human factors validation provides the primary evidence for a regulatory submission.

• Performance Metrics: Measures objective data like task success rates, error frequencies, and task completion times.
• Residual Risk Acceptance: Proves that any remaining use errors do not result in serious harm.
• Statistical Justification: Requires a pre-defined sample size (typically 15+ participants per distinct user group) and pass/fail criteria rooted in the risk analysis.

The translation of user needs and risk controls into a concrete user interface design. This encompasses all points of interaction, including hardware controls, software screens, labels, and instructional materials.

• Affordances & Signifiers: Design elements that visually communicate their function (e.g., a raised button invites pressing).
• Error Prevention: Constraints like forcing functions that prevent a user from proceeding without completing a critical safety check.
• Feedback Mechanisms: Ensuring the device provides immediate, unambiguous confirmation of user actions (visual, auditory, or haptic).

The proactive, systematic collection of real-world data after product launch to detect unforeseen use errors. This closes the loop between design intent and actual clinical practice.

• Complaint Analysis: Triaging incoming reports to identify patterns of user confusion or operational difficulty.
• CAPA Integration: Feeding usability findings into the Corrective and Preventive Action system to trigger design changes or labeling updates.
• Real-World Evidence: Analyzing data logs from connected devices to objectively measure how features are being used versus how they were intended to be used.

Two distinct phases of usability testing with different regulatory purposes.

• Formative Evaluation: Iterative, early-stage testing to explore user needs and identify design weaknesses. It is qualitative and drives design refinement.
• Summative Evaluation: A final, protocol-driven validation test to demonstrate that the final design is safe and effective for the intended users. It produces the objective evidence required for FDA premarket submissions.

A critical distinction in HFE terminology that shifts blame from the user to the design.

• Use Error: An action or inaction by the user that leads to a different result than intended by the manufacturer or expected by the user. It is a consequence of poor design.
• User Error: An outdated term implying fault lies with the user. Regulatory bodies now focus on use-related risk, which is mitigated through design, not training alone.

The foundational document for the entire usability engineering process, defining the context of use.

• Specifies the intended medical indication, patient population, and part of the body or tissue type.
• Defines the intended user profiles, including their education, knowledge, and potential physical or cognitive limitations.
• Describes the use environment, accounting for factors like lighting, noise, and distractions that could affect safe interaction.

A systematic breakdown of user-device interactions to isolate safety-critical steps.

• Task Analysis decomposes high-level goals into discrete physical and cognitive user actions.
• Critical Tasks are user actions that, if performed incorrectly or not performed at all, could lead to serious harm to the patient or user.
• Summative usability tests are specifically designed to observe the successful completion of these critical tasks.